HPRA grants GMP Certificate to Wockhardt’s Aurangabad facility

27 Mar 2019 Evaluate

Health Products Regulatory Authority, Ireland (HPRA) and UK MHRA have carried out joint Inspection of Shendra, Aurangabad facility of the Wockhardt. HPRA has granted GMP Certificate to Shendra, Aurangabad facility of the company which is valid for a period of three years i.e. up to January 31, 2022.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1176.90 -9.75 (-0.82%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×